Mild Cognitive Impairment Clinical Trial
Official title:
The Development and Evaluation of Multi-domain Attention Training for Older Adults With Mild Cognitive Impairment
Verified date | February 2020 |
Source | Ministry of Science and Technology, Taiwan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .
Status | Completed |
Enrollment | 60 |
Est. completion date | December 31, 2019 |
Est. primary completion date | May 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Participants must endorse at least two items from a list of frequent subjective memory complaints by patient and/or an informant - Objective memory impairment on neuropsychological tests of memory 1.5 SD or more below age/education norms - Clinical neurologic examination by the Mini-Mental State Examination (MMSE) score of 24 or higher - No impairment in personal activities of daily living (P-ADL) as determined by clinical interview with participant and family Exclusion Criteria: - The clinical diagnosis of dementia was based on the DSM-IV-TR - Active in another cognitive or memory-related training in the past year - Comorbid medical conditions that would predispose them to imminent functional decline or cognitive impairment - A diagnosis of major neurological or psychiatric illness history and/or behavioral problems that would sufficiently impair performance to make participation impossible - Severe losses in vision, hearing, or communicative ability |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ministry of Science and Technology, Taiwan |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in attention as measured by the Digit Span Task (DS). | The primary outcome indicators is executive attention assessed by the Digit Span Task (DS). | Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention. | |
Secondary | Change in attention as measured by the Trail Making Test (TMT). | The secondary outcome indicator is spatial orienting attention evaluated by the Trail Making Test. | Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |